(Mostly) Asia M&A: February 2020 Roundup
For the month of February, 21 new deals were discussed on Smartkarma with an overall announced deal size of ~US$24bn. Clicking on the company...
562 Views
Bumrungrad: Bangkok Dusit's Poor Diagnosis
Bangkok Dusit Med Service (BDMS TB) has made a Conditional Voluntary Tender Offer (CVTO) for 24.99% held Bumrungrad Hospital Pub Co (BH TB) at...
517 Views
BCH: Positive Sentiment from New Rate Adjustment for SSO Patients
Yesterday's analyst meeting came out with a positive tone. We maintain our BUY rating with a target price of Bt21.0 based on DCF on the back of...
488 Views
Jinxin Fertility Group: First-Day Trading Thoughts
Corrigenda: There is an error in this insight. Please note the correction below. Correction: In the last line of the first paragraph below, "......
645 Views
Jinxin Fertility Group IPO: Valuation Reasonable for the Trade-Offs
Jinxin Fertility Co Ltd (1951 HK) is a leading assisted reproductive service (ARS) provider in China and the US. It announced its IPO price...
1.1k Views